ReviewPediatric nephrology (Berlin, Germany)2026
Pediatric tumor lysis syndrome: the nephrologist's role in prevention and management.
Review in Pediatric nephrology (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tumor lysis syndrome (TLS) occurs frequently in pediatric oncology patients. It is a potentially life-threatening metabolic disorder that manifests when malignant cells lyse and overwhelm physiologic excretory capacity, resulting in significant clinical consequences including acute kidney injury (AKI), cardiac arrhythmias, multi-organ failure, and death. Related to high proliferation rates and sensitivity to chemotherapy, common childhood malignancies demonstrate a high risk for TLS. Electrolyte abnormalities and AKI feature prominently in TLS and emphasize the important role that pediatric nephrologists play in caring for patients with TLS. In this review, we will highlight risk stratification, preventive strategies, and management of pediatric TLS, including indications for kidney replacement therapy.
Indexed as
Identifiers
41806215What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.